{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:26:26Z","timestamp":1794709586230,"version":"4.9.1"},"reference-count":25,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Dermatitis\u00ae"],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:p>Patch testing, used in the assessment of allergic contact dermatitis, is ideally avoided in patients receiving immunosuppressive therapy because of concerns with reductions in accuracy; however, this is not well characterized in the literature. This systematic review summarizes patch testing results in patients receiving immunosuppressive therapy. We identified 16 studies, comprising 195 patients with dermatitis or psoriasis, who were patch tested while receiving immunosuppressants. Of these, 7 studies, comprising 85 patients with dermatitis, patch tests were performed before and during immunosuppression. Overall, 67.9% (n = 19) of the dermatitis patients receiving dupilumab maintained positive reactions to an allergen that previously graded as a 2+\/3+ reaction. Several immunosuppressants were also associated with positive patch test results for various allergens. These include dupilumab, cyclosporine, and low-dose prednisone (\u226410 mg\/d) for dermatitis, and tumor necrosis factor \u03b1 inhibitors, ustekinumab, and methotrexate for psoriasis. Ideally, it is preferable to patch test when patients are not receiving oral immunosuppressants or immunomodulators. However, clinicians may choose to assess the risks and benefits of patch testing for each patient given the impact of allergic contact dermatitis on patient quality of life.<\/jats:p>","DOI":"10.1097\/der.0000000000000726","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T09:54:13Z","timestamp":1619430853000},"page":"365-374","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":34,"title":["Patch Testing during Immunosuppressive Therapy: A Systematic Review"],"prefix":"10.1177","volume":"32","author":[{"given":"Asfandyar","family":"Mufti","sequence":"first","affiliation":[{"name":"From the, *Division of Dermatology, University of Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin D.","family":"Lu","sequence":"additional","affiliation":[{"name":"Michael G. DeGroote School of Medicine, Faculty of Medicine, Hamilton"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muskaan","family":"Sachdeva","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Toronto, Ontario"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Zaaroura","sequence":"additional","affiliation":[{"name":"From the, *Division of Dermatology, University of Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Kashetsky","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Memorial University, St. John's, Newfoundland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jensen","family":"Yeung","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard I.","family":"Maibach","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California San Francisco."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"DeKoven","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20132323"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0254"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000346"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000056"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2009.01695.x"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2004.00340.x"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2008.07040"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0b013e318275969f"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.09.028"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.08.027"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.01.023"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.4098"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12466"},{"issue":"4","key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1600-0536.1994.tb01998.x","article-title":"Can cyclosporin A help distinguish allergic from irritant patch test reactions?","volume":"31","author":"Vena GA","year":"1994","unstructured":"Vena GA, , Foti C, , Piazzola L, et al. Can cyclosporin A help distinguish allergic from irritant patch test reactions?. Contact Dermatitis, 1994; 31(4):256\u2013257.","journal-title":"Contact Dermatitis"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.03.020"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000357"},{"issue":"10","key":"e_1_3_1_18_2","first-page":"e377","article-title":"One-third of patients with therapy-resistant atopic dermatitis may benefit after patch testing","volume":"33","author":"L\u00f3pez-Jim\u00e9nez EC","year":"2019","unstructured":"L\u00f3pez-Jim\u00e9nez EC, , Marrero-Alem\u00e1n G. One-third of patients with therapy-resistant atopic dermatitis may benefit after patch testing. J Eur Acad Dermatol Venereol, 2019; 33(10):e377\u2013e378.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000048"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12901"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2009.09005"},{"issue":"6","key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/cod.12765","article-title":"Successful patch testing of a patient receiving anti\u2013interleukin-17 therapy with secukinumab: a case report","volume":"76","author":"Hamann D","year":"2017","unstructured":"Hamann D, , Zirwas M. Successful patch testing of a patient receiving anti\u2013interleukin-17 therapy with secukinumab: a case report. Contact Dermatitis, 2017; 76(6):378\u2013379.","journal-title":"Contact Dermatitis"},{"issue":"4","key":"e_1_3_1_23_2","first-page":"296","article-title":"Contact dermatitis, patch testing, and allergen avoidance","volume":"112","author":"Burkemper NM","year":"2015","unstructured":"Burkemper NM. Contact dermatitis, patch testing, and allergen avoidance. Mo Med, 2015; 112(4):296\u2013300.","journal-title":"Mo Med"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.03.009"},{"issue":"1","key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1046-199X(96)90029-9","article-title":"Excited skin syndrome","volume":"7","author":"Duarte I","year":"1996","unstructured":"Duarte I, , Almeida FA, , Proen\u00e7a NG. Excited skin syndrome. Am J Contact Dermatitis, 1996; 7(1):24\u201334.","journal-title":"Am J Contact Dermatitis"},{"issue":"2","key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1586\/eci.10.4","article-title":"Diagnostic approach in allergic and irritant contact dermatitis","volume":"6","author":"Ale IS","year":"2010","unstructured":"Ale IS, , Maibacht HA. Diagnostic approach in allergic and irritant contact dermatitis. Expert Rev Clin Immunol, 2010; 6(2):291\u2013310.","journal-title":"Expert Rev Clin Immunol"}],"container-title":["Dermatitis\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000726","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1097\/DER.0000000000000726","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000726","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:06:04Z","timestamp":1777399564000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0000000000000726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12,1]]}},"alternative-id":["10.1097\/DER.0000000000000726"],"URL":"https:\/\/doi.org\/10.1097\/der.0000000000000726","relation":{},"ISSN":["1710-3568","2162-5220"],"issn-type":[{"value":"1710-3568","type":"print"},{"value":"2162-5220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}